Basilea announces approval of antifungal Cresemba® (isavuconazole) for invasive aspergillosis in ChinaGlobeNewsWire • 01/13/22
3 Growth Stocks That Have Generated $179 Billion in Free Cash Flow in 12 MonthsThe Motley Fool • 01/12/22
Pfizer says its safe and effective to co-administer its Prevnar 20, COVID-19 shotsMarket Watch • 01/12/22
Positive Top-Line Results of Pfizer's Phase 3 Study Exploring Coadministration of PREVNAR 20™ With Pfizer-BioNTech COVID-19 Vaccine in Older Adults ReleasedBusiness Wire • 01/12/22
Exclusive-Pfizer to cut U.S. sales staff as meetings with healthcare providers move to virtualReuters • 01/11/22
Pfizer plans to ready hybrid shot to protect against omicron by March, says CEO BourlaMarket Watch • 01/11/22
Pfizer Inc. (PFE) Management Presents at 40th Annual J.P. Morgan Healthcare Conference (Transcript)Seeking Alpha • 01/11/22
Chile Latest Country To Roll Out 4th Covid Vaccine Shots — But Pfizer CEO Still Unsure Whether They're NecessaryForbes • 01/10/22
Exclusive: Pfizer plans to start human studies of its Omicron-specific COVID-19 vaccine before the end of JanuaryBusiness Insider • 01/10/22
Pfizer announces deal worth up to $1.3 billion with Beam; Beam's stock is up 4.9%Market Watch • 01/10/22